Search Results
Highlights from ESMO 2020 in gynecological cancers
ESMO 2020 Highlights on lenvatinib plus pembrolizumab in advanced solid tumours: LEAP-005
ESMO 2020 Highlights on nivolumab+cabozantinib as 1st line therapy for aRCC: The CheckMate 9ER study
ESMO 2020 Highlights on pembrolizumab in LA-HNSCC: The GORTEC 2015-01 “PembroRad” study
#ESMO21 Highlights on pembro + chemo in 1st-line metastatic cervical cancer: The KEYNOTE-826 study
#ESMO21 Highlights on maintenance olaparib in ovarian cancer previously treated with PARPi
OncLive News Network On Location: ESMO 2020 Day 1
ESMO Gynaecological Cancers Congress: key developments in ovarian cancer
ESMO Breast 2021 highlights
ESMO 2020 Expert Video Report on studying further advanced ovarian cancer
CRC highlights from ESMO WCGIC 2021
Highlights from ESMO Sarcoma & GIST 2022
